CWAN
Earnings in 2 days · May 7, 2026 · After close
Signal
Leaning Bullish1
Price
1
Move-0.17%Quiet session
Volume
1
Volume0.5× avgLight volume
Technical
1
RSIRSI 65Momentum positive
PRICE
Prev Close
24.21
Open
24.26
Day Range24.16 – 24.27
24.16
24.27
52W Range15.74 – 25.07
15.74
25.07
90% of range
VOLUME & SIZE
Avg Volume
5.5M
FUNDAMENTALS
P/E Ratio
-172.6x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.03
Market-like
Performance
1D
-0.17%
5D
+0.08%
1M
+0.88%
3M
+3.03%
6M
+39.15%
YTD
+0.21%
1Y
+6.38%
Best: 6M (+39.15%)Worst: 1D (-0.17%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +62% YoY · 67% gross margin
Valuation
FAIR
P/E not available
Health
STRONG
CR 1.8 · FCF $0.57/sh
Strong Buy
Key MetricsTTM
Market Cap$7.17B
Revenue TTM$731.37M
Net Income TTM-$38.81M
Free Cash Flow$164.29M
Gross Margin67.3%
Net Margin-5.3%
Operating Margin1.3%
Return on Equity-2.2%
Return on Assets-1.3%
Debt / Equity0.44
Current Ratio1.83
EPS TTM$-0.13
Alpha SignalsFull Analysis →
What Moves This Stock

Net new AUM wins and client additions, particularly large insurance carriers or asset managers with $10B+ portfolios

Annual recurring revenue (ARR) growth rate and dollar-based net retention metrics indicating upsell success

Operating margin expansion trajectory as the company transitions from growth investment mode toward profitability

Competitive win rates against legacy providers (Advent, SimCorp, SS&C) and retention of insurance clients facing IFRS 17 compliance deadlines

Macro Sensitivity
Economic Cycle

low - Revenue is contractually recurring and tied to AUM levels rather than transaction volumes. While severe market downturns reduce AUM and therefore revenue (estimated 0.3-0.5x beta to equity market movements), insurance clients maintain operations through cycles and regulatory reporting remains mandatory. New client additions may slow during recessions as IT budgets tighten, but retention remains high given mission-critical nature of investment accounting infrastructure.

Interest Rates

Rising interest rates have mixed but generally neutral impact. Higher rates compress valuation multiples for high-growth SaaS stocks (negative for stock price), but improve insurance industry profitability through higher investment income, potentially increasing IT budgets and AUM growth (positive for fundamentals). The company's minimal debt ($0.45 D/E ratio) limits direct financing cost sensitivity. Customer financing decisions for large implementations may extend during high-rate environments.

Key Risks

Technological disruption from cloud-native competitors or in-house development by largest asset managers seeking to internalize investment accounting capabilities

Regulatory changes reducing complexity of investment reporting requirements (unlikely but would reduce switching costs and pricing power)

Consolidation among insurance carriers and asset managers reducing total addressable client count, though offset by AUM concentration

Investor Profile

growth - Investors are attracted to 20%+ revenue growth, expanding TAM in financial services software, and operating leverage potential as the company scales toward profitability. The stock appeals to SaaS-focused growth investors willing to pay premium valuations (10.3x P/S) for mission-critical software with high retention and long-term margin expansion visibility. Recent volatility (-17% 1-year return despite +22.7% revenue growth) reflects broader SaaS multiple compression rather than fundamental deterioration.

Watch on Earnings
S&P 500 Index level as proxy for AUM growth on platform (equity market exposure drives ~40-50% of client portfolio values)Insurance industry combined ratio and ROE trends indicating sector health and IT spending capacityEnterprise SaaS valuation multiples (EV/Revenue for high-growth peers) as comparable valuation frameworkDollar-based net retention rate quarterly trends (target 110%+ indicates healthy upsell motion)
Health Radar
1 strong1 watch4 concern
27/100
Liquidity
1.83Watch
Leverage
0.44Strong
Coverage
0.2xConcern
ROE
-2.2%Concern
ROIC
0.3%Concern
Cash
$91MConcern
ANALYST COVERAGE11 analysts
HOLD
+1.6%upside to target
L $24.55
Med $24.55consensus
H $27.00
Buy
327%
Hold
764%
Sell
19%
3 Buy (27%)7 Hold (64%)1 Sell (9%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
RSI RangeRSI 65 — Bullish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 1.83 — healthy liquidity
Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 10.2%

+2.2% vs SMA 50 · +12.6% vs SMA 200

Momentum

RSI64.6
Positive momentum, not extended
MACD+0.17
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$25.07+3.7%
Current
$24.17
EMA 50
$23.71-1.9%
EMA 200
$22.08-8.7%
52W Low
$15.73-34.9%
52-Week RangeNear 52-week high
$15.7390th %ile$25.07
Squeeze SetupVolume-based
Distribution Pressure

Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.

20-Day Money Flow
Acc days:0
Dist days:6
Edge:+6 dist
Volume Context
Avg Vol (50D)3.8M
Recent Vol (5D)
4.0M+4%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 9 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$445.7M
$445.2M$446.8M
$0.44
±5%
High8
FY2025
$730.6M
$730.3M$731.3M
+63.9%$0.55+24.3%
±2%
High9
FY2026(current)
$943.0M
$937.5M$946.7M
+29.1%$0.70+28.0%
±6%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCWAN
Last 8Q
+4.0%avg beat
Beat 4 of 8 quartersMissed 2 Estimates rising
+11%
Q2'24
Q3'24
+9%
Q4'24
+18%
Q1'25
+8%
Q2'25
-8%
Q3'25
-7%
Q4'25
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d01
RBC CapitalOutperform → Sector Perform
Feb 25
DOWNGRADE
UBSNeutral
Jan 26
DOWNGRADE
JefferiesHold
Jan 16
DOWNGRADE
Piper SandlerUnderperform → Neutral
Dec 22
DOWNGRADE
Loop Capital MarketsBuy → Hold
Dec 22
DOWNGRADE
OppenheimerOutperform → Perform
Dec 22
DOWNGRADE
William BlairMarket Perform
Dec 22
DOWNGRADE
Goldman SachsNeutral → Buy
Aug 11
UPGRADE
OppenheimerPerform → Outperform
Jul 8
UPGRADE
Loop Capital MarketsBuy
Sep 24
UPGRADE
OppenheimerPerform
Jan 12
DOWNGRADE
Goldman SachsNeutral
Jul 13
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $690K sold · 30d window
Cox James SCFO
$179K
Apr 15
SELL
Cox James SCFO
$117K
Apr 15
SELL
Cox James SCFO
$34K
Apr 15
SELL
Cox James SCFO
$120K
Apr 15
SELL
Das SouvikChief Technolo…
$240K
Apr 8
SELL
Erickson Scott Stan…Chief Revenue …
$342K
Mar 31
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
HSBC HOLDINGS PLC
1.5M
2
ALPINE ASSOCIATES MANAGEMENT INC.
1.3M
3
SYQUANT CAPITAL SAS
975K
4
Nuveen, LLC
906K
5
Conestoga Capital Advisors, LLC
634K
6
Alberta Investment Management Corp
500K
7
CIBRA Capital Ltd
458K
8
CREDIT INDUSTRIEL ET COMMERCIAL
311K
News & Activity

CWAN News

20 articles · 4h ago

About

No description available.

Industry
Software Publishers
PeersTechnology(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
CWAN
$24.17-0.17%$7.2B+6187.8%-530.6%1500
$198.48+0.02%$4.8T40.2+6547.4%5560.3%1495
$276.83-1.18%$4.1T33.2+642.6%2691.5%1494
$413.62-0.20%$3.1T24.5+1493.2%3614.6%1477
$416.50-1.13%$2.0T79.1+2387.4%3619.8%1504
$576.45+6.31%$650.1B26.9+4885.1%2284.5%1534
$341.54-5.27%$556.9B128.4+3433.8%1251.5%1517
Sector avg-0.23%55.4+3653.9%2641.7%1503